Efficacy and safety of two treatment combinations of hypertension in very elderly patients

Archives of Gerontology and Geriatrics

Volumn 48, Issue 3, 2009, Pages 401-405

  Fogari, Roberto ^a   Zoppi, Annalisa ^a   Mugellini, Amedeo ^a   Corradi, Luca ^a   Lazzari, Pierangelo ^a   Preti, Paola ^a   Derosa, Giuseppe ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Amlodipine; Elderly hypertensive patient; Hypertension; Valsartan

Indexed keywords

AMLODIPINE PLUS VALSARTAN; ELECTROLYTE; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; PLACEBO; POTASSIUM; URIC ACID;

AGED; AGING; AMBULATORY MONITORING; ANKLE EDEMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NAUSEA; ORTHOSTATIC HYPOTENSION; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECUMBENCY; STANDING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; AMLODIPINE; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE MONITORING, AMBULATORY; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 62949182264     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.03.012     Document Type: Article

References (37)

1. Amery A., Brixko P., Clement D., De Schaepdryver A., Fagard R., Forte J., Henry J.F., Leonetti G., O'Malley K., Strasser T., Birkenhäger W., Bulpitt C., Deruyttere M., Dollery C., Forette F., Hamdy R., Joossens J.V., Lund-Johansen P., Petrie J., Tuomilehto J., and Williams B. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1 (1985) 1349-1354
2. Benz J.R., Black H.R., Graff A., Reed A., Fitzsimmons S., and Shi Y. Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo-controlled trial comparing combination therapy with monotherapy. J. Hum. Hypertens. 12 (1998) 861-866
3. Bulpitt C.J., Beckett N.S., Cooke J., Dumitrascu D.L., Gil-Extremera B., Nachev C., Nunes M., Peters R., Staessen J.A., and Thijs L. Hypertension in the Very Elderly Trial Working Group, Results of the pilot study for the Hypertension in the Very Elderly Trial. J. Hypertens. 21 (2003) 2409-2417
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., Roccella E.J., and and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
5. Clayton J.A., Rodgers S., Blakey J., Avery A., and Hall I.P. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br. J. Clin. Pharmacol. 61 (2005) 87-95
6. Dahlof B., Lindholm L.H., Hansson L., Schersten B., Ekbom T., and Wester P.O. Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-Hypertension). Lancet 338 (1991) 1281-1285
7. Franklin S.S. Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J. Hypertens. 17 Suppl. 5 (1999) S29-S36
8. Gong L., Zhang W., Zhu Y., Zhu J., Kong D., Pagé V., Ghadirian P., LeLorier J., and Hamet P. Shangai trial of nifedipine in the elderly (STONE). J. Hypertens. 14 (1996) 1237-1245
9. Groppelli A., Omboni S., Ravogli A., Villani A., Parati G., and Mancia G. Validation of the Spacelabs 90202 and 90297 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements. J. Hypertens. 9 Suppl. 3 (1991) S334-S335
10. Grossman H., and Messerli F.H. Effect of calcium antagonists on plasma norepinephrine levels, heart rate and blood pressure. Am. J. Cardiol. 80 (1997) 1453-1458
11. Gueyffier F., Bulpitt C., Boissel J.P., Schron E., Ekbom T., Fagard R., Casiglia E., Kerlikowske K., and Coope J. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet 353 (1999) 793-796
12. Hansson L., Hedner T., and Dahlof B. Prospective, randomized, open-label, blinded-end point (PROBE) study: a novel design for intervention trials. Blood Press. 1 (1992) 113-114
13. Hansson L., Lindholm L.H., Ekbom T., Dahlöf B., Lanke J., Scherstén B., Wester P.O., Hedner T., and De Faire U. Randomized trial of old and new antihypertensive drugs in the elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in old patients with Hypertension-2 study. Lancet 354 (1999) 1751-1756
14. Kannel W.B. Risk stratification in hypertension: new insights from the Framingham Study. Am. J. Hypertens. 13 Pt 2 (2000) 3S-10S
15. Kochar M., Guthrie R., Triscari J., Kassler-Taub K., and Reeves R.A. Matrix study of irbesartan with hydrochlorothiazide in mild to moderate hypertension. Am. J. Hypertens. 12 (1999) 797-805
16. Lipicky R.J. Trough:peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J. Hypertens. 12 (1994) S17-S18
17. Liu L., Wang J.G., Gong L., Liu G., Staessen J.A., and for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J. Hypertens. 16 (1998) 1823-1829
18. Mancia G., Omboni S., Ravogli A., Parati G., and Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Press. 4 (1995) 148-156
19. Mancia G., Omboni S., and Parati G. Assessment of antihypertensive treatment by ambulatory blood pressure. J. Hypertens. 15 Suppl. I (1997) S43-S50
20. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A.M., Kjeldsen S.E., Laurent S., Narkiewicz K., Ruilope L., Rynkiewicz A., Schmieder R.E., Struijker Boudier H.A., Zanchetti A., Vahanian A., Camm J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., Zamorano J.L., Kjeldsen S.E., Erdine S., Narkiewicz K., Kiowski W., Agabiti-Rosei E., Ambrosioni E., Cifkova R., Dominiczak A., Fagard R., Heagerty A.M., Laurent S., Lindholm L.H., Mancia G., Manolis A., Nilsson P.M., Redon J., Schmieder R.E., Struijker-Boudier H.A., Viigimaa M., Filippatos G., Adamopoulos S., Agabiti-Rosei E., Ambrosioni E., Bertomeu V., Clement D., Erdine S., Farsang C., Gaita D., Kiowski W., Lip G., Mallion J.M., Manolis A.J., Nilsson P.M., O'Brien E., Ponikowski P., Redon J., Ruschitzka F., Tamargo J., van Zwieten P., Viigimaa M., Waeber B., Williams B., and Zamorano J.L. Guidelines for the management of arterial hypertension. The task Force for the management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Eur. Heart J. 28 (2007) 1462-1536
21. Masaki K.H., Schatz I.J., Burchfiel C.M., Sharp D.S., Chiu D., Foley D., and Curb J.D. Orthostatic hypotension predicts mortality in elderly men. The Honolulu Heart Program. Circulation 98 (1998) 2290-2295
22. Moriguchi K., Rakugi H., Nagata S., Nagai R., Moriguchi A., Okamura A., Ohishi M., Higaki J., and Ogihara T. Impairment of instantaneous autonomic regulation relates to blood pressure fall immediately after standing in the elderly and hypertensives. Hypertens. Res. 29 (2006) 557-566
23. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br. Med. J. 304 (1992) 405-412
24. Omboni S., Parati G., Zanchetti A., and Mancia G. Calculation of trough:peak ratio of antihypertensive treatment from ambulatori blood pressure. Methodological aspects. J. Hypertens. 13 (1995) 1105-1112
25. Ostchega Y., Dillon C.F., Hughes J.P., Carrol M., and Yoon S. Trends in hypertension prevalence, awareness, treatment and control in older U.S. adults: data from the national health and nutrition examination survey 1988 to 2004. J. Am. Geriatr. Soc. 55 (2007) 1056-1065
26. Palatini P., and Julius S. Heart rate and the cardiovascular risk. J. Hypertens. 15 (1997) 3-17
27. Parati G., Omboni S., Rizzoni D., Agabiti-Rosei E., and Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J. Hypertens. 16 (1998) 1685-1691
28. Puschett J.B. Diuretics. In: Oparil S., and Weber M.A. (Eds). Hypertension: A Companion to Brenner and Rector's The Kidney (2000), WB Saunder Company, Philadelphia 584-590
29. Rutan G.H., Hermanson B., Bild D.E., Kittner S.J., LaBaw F., and Tell G.S. Orthostatic hypotension in older adults: the Cardiovascular Health Study. Hypertension 19 (1992) 508-519
30. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Med. Assoc. 265 (1991) 3255-3264
31. Sica D.A. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 62 (2002) 443-462
32. Smith T.R., Philipp T., Vaisse B., Bakris G.L., Wernsing M., Yen J., and Glazer R. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J. Clin. Hypertens. 9 (2007) 355-364
33. Staessen J.A., Fagard R., Thijs L., Celis H., Arabidze G.G., Birkenhäger W.H., Bulpitt C.J., de Leeuw P.W., Dollery C.T., Fletcher A.E., Forette F., Leonetti G., Nachev C., O'Brien E.T., Rosenfeld J., Rodicio J.L., Tuomilehto J., and Zanchetti A. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350 (1997) 757-764
34. Thomas G.N., Chan P., and Thomlinson B. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Drugs Aging 23 (2006) 131-155
35. Turnheim K. Drug therapy in the elderly. Exp. Gerontol. 39 (2004) 1731-1738
36. Wilson I.M., and Freis E.D. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effects of chlorothiazide. Circulation 20 (1959) 1028-1036
37. Zanchetti A. Contribution of fixed low-dose combinations to initial therapy in hypertension. Eur. Heart. J. 1 Suppl. L (1999) L5-L9